Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P970051/S237

Cochlear Nucleus System

Cochlear Americas · Decision date Sep 2, 2025

FDA DECISIONP970051/S237

What did the FDA approve?

FDA records P970051/S237 as a supplement to PMA P970051, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Sep 2, 2025.

FDA approval order statement

This revision includes data from an IDE study (G190269) to complete the pediatric recruitment arm of this PAS. These additional data are from 23 subjects whose audiometric inclusion criteria overlap with the inclusion criteria for this PAS.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Ear, Nose, Throat
Decision date
Sep 2, 2025
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P970051/S237
Regulatory pathway
PMA supplement
Product code
MCM
Decision code
APPR
Decision date
Sep 2, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

For the original device and its historical approval scope, see PMA P970051. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P970051 · Original PMA

    NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  2. P970051/S234 · Related supplement

    Nucleus 24 Cochlear Implant System

  3. P970051/S237 received

    Application receipt date recorded by FDA.

  4. P970051/S235 · Related supplement

    Nucleus 24 Cochlear Implant System

  5. P970051/S237 · FDA decision

    Normal 180 Day Track No User Fee

  6. P970051/S238 · Related supplement

    Nucleus 24 Cochlear Implant System

  7. P970051/S236 · Related supplement

    Nucleus 24 Cochlear Implant System

  8. P970051/S240 · Related supplement

    NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  9. P970051/S242 · Related supplement

    Nucleus 24 Cochlear Implant System

  10. P970051/S244 · Related supplement

    Nucleus 24 Cochlear Implant System

Timeline entries are records held by MedtechLedger for P970051. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P970051

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA approvalJun 25, 1998FDA
Cochlear AmericasPMA supplementJul 24, 2025FDA
Cochlear AmericasPMA supplementAug 6, 2025FDA
Cochlear AmericasPMA supplementSep 26, 2025FDA
Cochlear AmericasPMA supplementOct 16, 2025FDA
Cochlear AmericasPMA supplementDec 19, 2025FDA
Cochlear AmericasPMA supplementApr 30, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA
Advanced BionicsPMA supplementSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cochlear Americas

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10350 Park Meadows Dr., Lone Tree, CO, 80124

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records